We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Efficacy and Tolerability of BAF312 in Patients With Polymyositis and Dermatomyositis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01148810
Recruitment Status : Terminated
First Posted : June 22, 2010
Last Update Posted : August 1, 2013
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : June 2012
  Study Completion Date : June 2012
  Certification or Request for Extension to Delay Results Submission: July 25, 2013